Dr Reddy's Laboratories Ltd
(NYSE:RDY)
$
78.04
1.99 (2.62%)
Market Cap: 13.00 Bil
Enterprise Value: 12.26 Bil
PE Ratio: 19.52
PB Ratio: 3.87
GF Score: 90/100 - Q4 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptMay 07, 2024$71.34 (-4.73%)Earnings
- Q3 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJan 30, 2024$69.39 (-0.93%)Earnings
- Half Year 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptOct 27, 2023$65.05 (+0.70%)Earnings
- Q1 2024 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJul 26, 2023$68.05 (+3.25%)Earnings
- Q4 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptMay 10, 2023$58.55 (-3.01%)Earnings
- Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call TranscriptMar 16, 2023
- Q3 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJan 25, 2023$52.36 (+0.89%)Earnings
- Q2 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptOct 28, 2022$55.27 (+1.32%)Earnings
- Q1 2023 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJul 28, 2022$52.33 (-3.81%)Earnings
- Dr Reddy's Laboratories Ltd Investor Day TranscriptJun 21, 2022
- Q4 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptMay 19, 2022$51.35 (+2.74%)Earnings
- Q3 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJan 28, 2022$55.95 (+1.12%)Earnings
- Q2 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptOct 29, 2021$61.44 (+0.61%)Earnings
- Q1 2022 Dr Reddy's Laboratories Ltd Earnings Call TranscriptJul 27, 2021$63.62 (-12.38%)Earnings
- Q4 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptMay 14, 2021$72 (-0.74%)Earnings
- Q3 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJan 29, 2021$61.28 (-7.24%)Earnings
- Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q2 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptOct 28, 2020$64.89 (-4.60%)Earnings
- Q1 2021 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJul 29, 2020$58.62 (+7.60%)Earnings
- Q4 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptMay 20, 2020$51.74 (+6.31%)Earnings
- Q3 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJan 27, 2020$44.22 (+5.29%)Earnings
- Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q2 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptNov 01, 2019$39.84 (+1.76%)Earnings
- Q1 2020 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptJul 29, 2019$37.8 (-3.08%)Earnings
- Q4 2019 Dr.Reddy's Laboratories Ltd Earnings Call TranscriptMay 17, 2019$39.38 (-1.82%)Earnings
Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021 / 04:00PM GMT
Release Date Price:
$71.76
(-0.40%)
Neha Manpuria
JPMorgan Chase & Co, Research Division - Analyst
Hello, and welcome to the JPMorgan Healthcare Conference. I am Neha Manpuria, the India Health Care Analyst at JPMorgan. It's my pleasure to introduce Mr. Erez Israeli, the CEO of Dr. Reddy's. We will be having a fireside chat in this session and try to address questions on growth strategies of Reddy's. Thank you so much for joining us for this session, sir. It is a pleasure to host you. If you don't mind me directly moving into Q&A, I can start.
Questions & Answers
Erez Israeli;s Laboratories Limited;CEO;Member of the Management Council
Dr. Reddy
'-&
Sure. Thank you for having me.
Neha Manpuria
JPMorgan Chase & Co, Research Division - Analyst
So the first question that I have is Dr. Reddy's today probably has a very well-balanced business with a growing emerging market presence, improving position in India post the Wockhardt acquisition and a strong U.S. pipeline. From here on,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)